203 related articles for article (PubMed ID: 16814944)
1. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
Karg A; Dinç ZA; Başok O; Uçvet A
Pathol Res Pract; 2006; 202(8):577-83. PubMed ID: 16814944
[TBL] [Abstract][Full Text] [Related]
2. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
Weed DT; Gomez-Fernandez C; Pacheco J; Ruiz J; Hamilton-Nelson K; Arnold DJ; Civantos FJ; Zhang J; Yasin M; Goodwin WJ; Carraway KL
Head Neck; 2004 Apr; 26(4):353-64. PubMed ID: 15054739
[TBL] [Abstract][Full Text] [Related]
3. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
Tsutsumida H; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Batra SK; Imai K; Yonezawa S
Lung Cancer; 2007 Feb; 55(2):195-203. PubMed ID: 17126950
[TBL] [Abstract][Full Text] [Related]
4. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways.
Jepson S; Komatsu M; Haq B; Arango ME; Huang D; Carraway CA; Carraway KL
Oncogene; 2002 Oct; 21(49):7524-32. PubMed ID: 12386815
[TBL] [Abstract][Full Text] [Related]
5. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor.
Komatsu M; Jepson S; Arango ME; Carothers Carraway CA; Carraway KL
Oncogene; 2001 Jan; 20(4):461-70. PubMed ID: 11313977
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic value of c-erbB2 expression in non-small cell lung cancer (NSCLC).
Turken O; Kunter E; Cermik H; Isitmangil T; Kandemir G; Yaylaci M; Ozturk A
Neoplasma; 2003; 50(4):257-61. PubMed ID: 12937837
[TBL] [Abstract][Full Text] [Related]
7. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland.
Arango ME; Li P; Komatsu M; Montes C; Carraway CA; Carraway KL
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2749-56. PubMed ID: 11687512
[TBL] [Abstract][Full Text] [Related]
8. MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.
Miyahara N; Shoda J; Ishige K; Kawamoto T; Ueda T; Taki R; Ohkohchi N; Hyodo I; Thomas MB; Krishnamurthy S; Carraway KL; Irimura T
Eur J Cancer; 2008 May; 44(7):1048-56. PubMed ID: 18397823
[TBL] [Abstract][Full Text] [Related]
9. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
Weed DT; Gomez-Fernandez C; Yasin M; Hamilton-Nelson K; Rodriguez M; Zhang J; Carraway KL
Laryngoscope; 2004 Aug; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
[TBL] [Abstract][Full Text] [Related]
10. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
Zhang S; Qiu X; Gu Y; Wang E
Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765
[TBL] [Abstract][Full Text] [Related]
13. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
Yokoyama A; Shi BH; Kawai T; Konishi H; Andoh R; Tachikawa H; Ihara S; Fukui Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):200-3. PubMed ID: 17292332
[TBL] [Abstract][Full Text] [Related]
14. Non-apoptotic desquamation of cells from corneal epithelium: putative role for Muc4/sialomucin complex in cell release and survival.
Lomako J; Lomako WM; Decker SJ; Carraway CA; Carraway KL
J Cell Physiol; 2005 Jan; 202(1):115-24. PubMed ID: 15389535
[TBL] [Abstract][Full Text] [Related]
15. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
[TBL] [Abstract][Full Text] [Related]
16. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
17. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Liu D; Nakano J; Ishikawa S; Yokomise H; Ueno M; Kadota K; Urushihara M; Huang CL
Lung Cancer; 2007 Dec; 58(3):384-91. PubMed ID: 17728005
[TBL] [Abstract][Full Text] [Related]
19. Imbalance of cell proliferation and apoptosis during progression of lung carcinomas.
Mattern J; Volm M
Anticancer Res; 2004; 24(6):4243-6. PubMed ID: 15736479
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
